Why is there still no licensed vaccine for Bundibugyo ebolavirus? Lessons from the 2026 outbreaks in Uganda and the Democratic Republic of Congo
Aniso Mohamed Abdi, Ahmed Mohamed Omar, Ilyas Abdullahi Khalif, Abdirahman Mohamed Adan, Sharmake Gaiye Bashir · 2026
Read Why is there still no licensed vaccine for Bundibugyo ebolavirus? Lessons from the 2026 outbreaks in Uganda and the Democratic Republic of Congo by Aniso Mohamed Abdi, Ahmed Mohamed Omar, Ilyas Abdullahi Khalif, Abdirahman Mohamed Adan, Sharmake Gaiye Bashir (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13285621.txt.
Description
Why does Bundibugyo ebolavirus still lack a licensed vaccine? Aniso Mohamed Abdi and co-authors press the question in a 2026 letter after fresh outbreaks in Uganda and the Democratic Republic of Congo. Licensed Ebola shots guard only the Zaire species, leaving Bundibugyo and Sudan species bare despite repeat deadly outbreaks.
Animal proof for Bundibugyo and mixed-species shots exists, so the block is not science, the writers argue. Weak profit pull stalls late trials for germs that strike rarely in poor lands. Even Zaire shot access lags where risk runs high. The letter calls the gap a structural failure of preparedness and urges funding paths that do not wait for rich markets.
Catalog record
| CREATOR | Aniso Mohamed Abdi, Ahmed Mohamed Omar, Ilyas Abdullahi Khalif, Abdirahman Mohamed Adan, Sharmake Gaiye Bashir |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6874 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |